Clinical Trial

Flyte Device for Improving Urinary Incontinence Among Endometrial and Cervical Cancer Survivors Who Have Undergone Radiation Therapy

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This clinical trial studies how well and how easy it is to use a device called Flyte in improving problems with bladder control (urinary incontinence) among endometrial and cervical cancer survivors who have undergone radiation therapy. Urinary incontinence is common after pelvic radiation therapy and can affect daily life and well-being. Access to in-person pelvic floor physical therapy can be limited. The Flyte device is designed for in-home use to deliver a series of mechanical vibrations at a specific frequency while the pelvic floor muscles are contracting and relaxing (i.e., normal, guided Kegel exercises). This treatment is called mechanotherapy. The Flyte device may improve urinary incontinence symptoms, as well as overall quality of life among endometrial and cervical cancer survivors who have undergone radiation therapy.
Trial Details
NCT Number NCT07662824
Lead Sponsor Mayo Clinic
Conditions Cervical Carcinoma, Endometrial Carcinoma, Overactive Bladder, Voiding Disorders
Enrollment 44 participants
Start Date 2026-08-13
Primary Completion 2028-08-13 (estimated)
Study Completion 2028-08-13 (estimated)
Updated on ClinicalTrials.gov 2026-06-23